Total raised: $10M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.06.2024 | Seed | $10M | - |
Mentions in press and media 3
| Date | Title | Description |
| 24.06.2024 | EpilepsyGTx Raises $10M in Seed Funding | EpilepsyGTx, a London, UK-based biotechnology company focused on research and development of gene therapies to treat focal refractory epilepsy, raised $10M in Seed funding. The round was led by UCL Technology Fund, with participation from H... |
| 24.06.2024 | EpilepsyGTx announces a $10M fundraise to complete the CTA-enabling nonclinical package for lead program EPY201 | LONDON–(BUSINESS WIRE)–June 24, 2024– EpilepsyGTx, a biotechnology company focused on research and development of cutting-edge gene therapies to treat focal refractory epilepsy, today announced it has raised a total of $10 million in seed f... |
| - | EpilepsyGTx | “Home | EpilepsyGTx ” |